Literature DB >> 3888947

Airway reactivity and lung function in triiodothyronine-induced thyrotoxicosis.

R S Irwin, M R Pratter, D H Stivers, L E Braverman.   

Abstract

To evaluate the possible relationship between asthma and hyperthyroidism, airway reactivity and lung function were prospectively compared in healthy volunteers before, during, and after liothyronine (triiodothyronine, T3)-induced hyperthyroidism. Base-line evaluation of the 10 subjects included clinical evaluation, thyroid and pulmonary function tests, and airway reactivity assessed by methacholine inhalational challenge (MIC). All studies were normal. During T3-induced hyperthyroidism, no subject developed respiratory symptoms or changes in pulmonary function or airway reactivity. The mean percent change in forced expiratory volume at 1 s from base line (delta FEV1) of -2.4 +/- 3.0 after MIC was not significantly different from that obtained before T3 administration (-1.4 +/- 1.5, P greater than 0.2). When all serum T3 concentrations and delta FEV1 values before, during and after T3-induced hyperthyroidism were compared, there was no significant correlation. We conclude that T3-induced hyperthyroidism of 3-wk duration has no effect on airway reactivity or lung function in normal volunteers.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3888947     DOI: 10.1152/jappl.1985.58.5.1485

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  3 in total

1.  Humoral control of airway tone.

Authors:  N C Thomson; K D Dagg; S G Ramsay
Journal:  Thorax       Date:  1996-05       Impact factor: 9.139

2.  Effects of hypothyroidism on bronchial reactivity in non-asthmatic subjects.

Authors:  S Wieshammer; F S Keck; A C Schäuffelen; H von Beauvais; H Seibold; V Hombach
Journal:  Thorax       Date:  1990-12       Impact factor: 9.139

3.  Effect of hyperthyroidism on bronchial reactivity in non-asthmatic patients.

Authors:  J A Roberts; A R McLellan; W D Alexander; N C Thomson
Journal:  Thorax       Date:  1989-07       Impact factor: 9.139

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.